journal article·2016-06

Antibacterial Bioglass‐Derived Scaffolds: Innovative Synthesis Approach and Characterization

Marta Miola, Enrica Verné, Chiara Vitale‐Brovarone, Francesco Baino

Publisher page

Abstract

Prevention and successful treatment of implant infection following bone surgery are critical challenges to avoid additional stress, disease, and any extra‐surgery to patients. We investigated the feasibility of a new synthesis method to prepare a bioactive glass‐ceramic scaffolds doped with silver, an antibacterial element. Scaffolds were fabricated by sponge replication method and silver was incorporated in the glass‐based slurry that infiltrates the template using silver nitrate as a precursor. The silver‐doped scaffolds mimic closely the cancellous bone in terms of 3‐D trabecular architecture and mechanical properties, were highly bioactive as demonstrated by the in vitro formation of a surface hydroxyapatite layer upon soaking in simulated body fluids, and exhibited good antibacterial properties against Staphylococcus aureus , a common bacterial strain involved in postsurgical infections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Applied Science and Technology Department Institute of Materials Physics and Engineering Politecnico di Torino Corso Duca degli Abruzzi 24 10129 Torino Italy

References (33)

Show source-provided references
1. 10.1016/j.actbio.2012.08.02310.1016/j.actbio.2012.08.023 ↗
2. 10.5301/JABFM.2012.927010.5301/JABFM.2012.9270 ↗
3. 10.1016/j.cej.2007.07.08310.1016/j.cej.2007.07.083 ↗
4. 10.1007/s10856-011-4240-810.1007/s10856-011-4240-8 ↗
5. 10.1007/s10856-006-0434-x10.1007/s10856-006-0434-x ↗
6. 10.1016/j.actbio.2011.10.01310.1016/j.actbio.2011.10.013 ↗
7. 10.1016/j.biomaterials.2012.09.06610.1016/j.biomaterials.2012.09.066 ↗
8. 10.1016/j.jnoncrysol.2013.04.02510.1016/j.jnoncrysol.2013.04.025 ↗
9. 10.1016/j.ijantimicag.2009.01.01710.1016/j.ijantimicag.2009.01.017 ↗
10. 10.1007/s10856-008-3617-910.1007/s10856-008-3617-9 ↗
11. 10.1016/j.actbio.2006.07.01210.1016/j.actbio.2006.07.012 ↗
12. 10.1016/j.jeurceramsoc.2012.10.01610.1016/j.jeurceramsoc.2012.10.016 ↗
13. 10.1016/j.actbio.2013.02.02610.1016/j.actbio.2013.02.026 ↗
14. 10.1111/j.1475-1305.2008.00417.x10.1111/j.1475-1305.2008.00417.x ↗
15. 10.1016/j.scriptamat.2003.09.04610.1016/j.scriptamat.2003.09.046 ↗
16. 10.1007/s10856-006-0111-010.1007/s10856-006-0111-0 ↗
17. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
18. National Committee for Clinical Laboratory Standard M2‐A9 · 2006
19. 10.1016/j.ijsu.2007.05.00110.1016/j.ijsu.2007.05.001 ↗
20. 10.1177/088532821142919310.1177/0885328211429193 ↗
21. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
22. 10.1007/s10856-008-3605-010.1007/s10856-008-3605-0 ↗
23. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
24. 10.1243/095441198153390810.1243/0954411981533908 ↗
25. 10.1177/088532821037214910.1177/0885328210372149 ↗
26. 10.1007/s10856-006-0432-z10.1007/s10856-006-0432-z ↗
27. 10.1016/j.actamat.2007.01.02910.1016/j.actamat.2007.01.029 ↗
28. 10.1007/s00223-001-2132-510.1007/s00223-001-2132-5 ↗
29. 10.1016/j.jeurceramsoc.2016.01.01110.1016/j.jeurceramsoc.2016.01.011 ↗
30. 10.1016/j.biomaterials.2005.11.02510.1016/j.biomaterials.2005.11.025 ↗
31. 10.1016/j.matlet.2014.02.05710.1016/j.matlet.2014.02.057 ↗
32. 10.1179/174367508X30653210.1179/174367508X306532 ↗
33. 10.1007/s10856-005-4422-310.1007/s10856-005-4422-3 ↗